Medpacto: Australia clears Phase 1 trial for MP2021
AI reading
★★★ Bullish · Material event
Australia clears Phase 1 clinical trial
An AI model read the opening section of the filing and rated it relative to the company's size. It can be wrong, so check the original filing on DART (Korean).
Other filings by Medpacto
- 09.18 ★★★ MedPacto seeks to amend Vactosertib Phase 1/2 trial protocol for osteosarcoma.
- 09.18 ★★ MedPacto files for MFDS approval to amend Phase 1/2 trial for Vactosertib in osteosarcoma patients.
- 09.18 ★★ MedPacto receives MFDS approval to amend Phase 1/2 trial for Vactosertib in osteosarcoma patients.
- 09.15 ★★★ MedPacto receives approval to amend Vactosertib monotherapy Phase 1/2 trial for osteosarcoma.
For information only. Not investment advice.